North East Foot & Ankle Symposium 2024

The North East Foot & Ankle Symposium returned for its 10th edition on May 10th 2024 at the Riverside Stadium Middlesbrough Football Club.

Course organisers Rachael Graham (North East & Scotland Territory Manager, TRBC UK) Mr Rajiv Limaye (Consultant Orthopaedic Foor & Ankle Surgeon, North Tees & Hartlepool NHS FT) and Dr Peddada Raju (MSk Consultant Radiologist, North Tees & Hartlepool NHS FT) were delighted to once again host a full day of quality CPD, alongside a wider multi-disciplinary faculty of orthopaedic surgeons, senior advanced podiatry and physiotherapy practitioners and allied healthcare professionals. Appealing to a national audience of 81 delegates, the day consisted of an interactive mix of lectures and workshops.

The 10th NEFAS was the perfect platform to showcase our new partnership with Clarius Mobile Health - manufacturer of a range of wireless handheld ultrasound scanners. The Clarius HD3 range offers high-quality point-of-care ultrasound for a wide-range of diagnostic imaging and procedural guidance; aiding clinician confidence and accuracy with high-resolution imaging of joints, tendons, ligaments, cartilage and muscles.

TRB Chemedica UK Managing Director, Mr Alex Flanagan, said: ‘We had been looking at various ultrasound product offerings for some time. Our premium Ostenil Range viscoelastic injectables – for joints and tendons - are often delivered under ultrasound guidance, and I was very interested in forming an alliance with a manufacturer who could provide a highly portable and affordable, cable-free device, which also offered exceptional resolution. The moment I was introduced to the Clarius HD3 range I knew it was exactly what we needed. The build quality is fantastic, connecting the handheld unit to a mobile phone, tablet, or laptop is quick and easy, and the integrated software features such as Voice Control, needle image enhancement, and Doppler are extremely helpful.’

Beth Alderton, Surgical Care Practitioner, presented ‘Landmark Injection Techniques’ including Ostenil Plus and Ostenil Tendon as safe and effective physiologic treatment options for degenerative or traumatic change to synovial joints and tendons. Then joined Mr Mohit Sethi (Consultant Orthopaedic Foor & Ankle Surgeon) and Lynne Robertson Mc-Partlin (SCP) to lead a practical hands-on landmark guided injection technique workshop, featuring our foot & ankle training models.

Any healthcare professional suitably qualified in injection therapy can offer Ostenil Range treatment - licensed as a medical device and not a pharmaceutical, an independent prescribing qualification is not required. It should further be highlighted, despite recent PRP treatment revokes by the CSP and RCPod, the Ostenil Range of HA injections (for both intra-articular use and tendinopathies) remain a viable treatment option by injection-qualified clinicians.

We would like to extend a big thank you to all additional sponsors of the event: North East Muscoloskeletal Society (NEMS), Tees Valley Hospital, GE Healthcare, Arthrex, Stryker, Mercury Ortho and OPED UK.

Back to blog